Delivery Order SPE2DB22D3004-SPE2DB24FQA98

Award Date 4/18/24
Potential Completion Date 4/19/24
Potential Value $3.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $47,225.69 firm fixed-price delivery order is for the supply of 4,567,027,993 units of the drug Meloxicam 15 mg Tablet. The contract has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with ID SPE2DB24D2105|SPE2DB25FAPKF, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $83,795.68, is a delivery order for 4,567,669,334 units of the prescription drug Meloxicam 15 mg tablet. The contract has a completion date of March 24, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award SPE2DB20D3104|SPE2DB25FV5N1 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,053.29 firm fixed-price delivery order is for the supply of 4,567,394,067 units of the drug Meloxicam 15 mg tablets. The contract has an ultimate completion date of February 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with ID SPE2DB22D3004|SPE2DB24FPH40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $45,412.58, is for the delivery of meloxicam 15 mg tablets. It is a firm fixed-price delivery order contract with a completion date of February 14, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,218.84, is for the delivery of 4,567,362,662 units of Meloxicam 15 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 25, 2025. The award is not designated as a Set-Aside contract....
This federal contract award, with an ID of SPE2DB22D3004|SPE2DB24FPJ88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 180 tablets of the medication Meloxicam 15 mg, with a ceiling value of $4,978.00 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this contract, which is a delivery order under a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $5,954.53, to provide Meloxicam 7.5 mg tablets to support military healthcare programs. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This federal contract award, valued at $1,359.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567582751 MELOXICAM 7.5 MG TABLET 90S, a pharmaceutical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $15,703.90, is a Firm Fixed Price delivery order without any set-aside designation. It is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,095.37 firm-fixed-price delivery order is for the provision of pharmaceutical products and medical supplies, including a wide range of prescription medications, over-the-counter drugs, and critical care materials such as syringes and test kits. This award is not associated with a set-aside program. Amerisourcebergen...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB24FQA98
    Delivery Order

This federal contract award, with ID SPE2DB22D3004|SPE2DB24FQA98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,273.54 firm fixed-price delivery order is for the supply of 4,564,325,587 units of the prescription medication Meloxicam 15 mg Tablet. This award is not associated with a set-aside program.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 7/18/24, 9:27 AM